Health Care & Hospital Law,
Civil Litigation
Jul. 13, 2021
No link between J&J opioids and sales in California, expert testifies
Laurentius Marais of Compass Lexecon in Chicago testified the sale of three prescription drugs made by Janssen Pharmaceuticals Inc. — a Johnson & Johnson subsidiary — consisted of less than 1% of the total opioid drug sales in the state between 1997 and 2018.
There is no link between California's opioid crisis and the sale of three Johnson & Johnson pain drugs a statistics expert said Monday during a $50 billion bench trial nearing its end in Orange County.
Statistics expert Laurentius Marais of Compass Lexecon in Chicago testified the sale of three prescription drugs made by Janssen Pharmaceuticals Inc. -- a Johnson & Johnson subsidiary -- consisted of less than 1% of the total...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Health Care & Hospital Law, Civil Litigation
State’s opioid trial goes on, seeks twice the amount of global settlement
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Plaintiffs urge all states to agree to $26B opioid deal, California case nears end
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
6 states not yet in national opioid settlement
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
California joins opponents of $4.5B Purdue Pharma settlement
By Craig Anderson
Health Care & Hospital Law, Civil Litigation
Former J&J medical consultant testifies in OC opioid trial
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Most opioid addicts had history of drug abuse, doctor testifies
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
No evidence promotion increases opioid use, economist testifies
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Drug companies open defense with opioid advocate
By Blaise Scemama
